Management & Regulatory

Can Seton Coastside Medical Center Overcome Its Challenges?
Management & Regulatory Can Seton Coastside Medical Center Overcome Its Challenges?

State officials and local supervisors are currently locked in a high-stakes standoff with the facility’s owners to ensure that critical acute care beds are not permanently lost. This situation has left the residents of Moss Beach and the surrounding Coastside area navigating a landscape of medical

WuXi Biologics Leads Industry in Sustainable Biopharma Innovation
Management & Regulatory WuXi Biologics Leads Industry in Sustainable Biopharma Innovation

Securing an MSCI AAA ESG rating and an EcoVadis Platinum Medal places WuXi Biologics in the top 1% of companies evaluated for environmental and social governance. This landmark achievement underscores the organization's role as a dominant force in the global healthcare market, particularly as it

Hims & Hers Navigates FTC Lawsuit and Strategic Pivot
Management & Regulatory Hims & Hers Navigates FTC Lawsuit and Strategic Pivot

Hims & Hers is currently navigating a complex period of transition as it trades its historical high-margin profile for a dominant position in the weight-loss sector. Operating at a volatile crossroads where rapid corporate expansion meets intense federal oversight, the leading telehealth platform

Eli Lilly and Novo Nordisk Vie for GLP-1 Market Dominance
Management & Regulatory Eli Lilly and Novo Nordisk Vie for GLP-1 Market Dominance

Although 75 percent of the public believes weight-loss drugs are used for cosmetic reasons, 66 percent still find their use to be socially acceptable in modern society. This fundamental shift in perception coincides with the rise of glucagon-like peptide-1 receptor agonists, which have

Why Is Paying Cash Cheaper Than Using Your Health Insurance?
Management & Regulatory Why Is Paying Cash Cheaper Than Using Your Health Insurance?

When a hospital employee advised a patient to bypass her insurance provider, the cost of her procedure dropped by sixty percent, exposing deep systemic inefficiencies. This paradox is common in the healthcare landscape of 2026, where administrative complexity often inflates prices far beyond the

SCHOTT Pharma Sets New Science-Based Climate Targets
Management & Regulatory SCHOTT Pharma Sets New Science-Based Climate Targets

The move away from carbon offsetting signals a maturation in corporate sustainability where physical decarbonization takes precedence over accounting-based neutrality claims. This evolution reflects a growing understanding that the pharmaceutical industry must confront its environmental impact

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later